Navigation Links
GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Date:2/16/2012

ORLANDO, Fla., Feb. 16, 2012 /PRNewswire/ -- GeneLink Biosciences, Inc. (OTCBB: GNLK), a leading consumer genomics biotech company, has completed the sale of the stock of its wholly owned direct-selling subsidiary GeneWize Life Sciences, Inc. (GeneWize)  to Capsalus Corp. (OTCBB: WELL), another public company operating in the health and wellness marketplace.  As previously disclosed, GeneLink and Capsalus executed definitive agreements for the sale of GeneWize on October 13, 2011 and GeneLink obtained shareholder approval of the transaction at a Special Shareholders Meeting on January 25, 2012.

GeneLink is a leader in consumer genomics, combining genetic science, wellness and customization to create innovative consumer products, including skincare and nutritional supplements personalized to reflect important elements of the individual customer's genetic profile. Through its operation of GeneWize, GeneLink has generated more than $25 million in revenues over the past three years, demonstrating the commercial viability of these DNA-customized products.

"The sale of GeneWize is an important step in GeneLink's strategy of leveraging the strengths of its sales and marketing partners in order to focus on the company's core competencies, and thus accelerate its growth," said Bernard L. Kasten Jr., M.D., GeneLink's Chairman and CEO.   "We are already impressed with the commitment and resources which Capsalus and its partners are bringing to GeneWize.  We would like nothing more than to see GeneWize and its brand partners flourish while supporting and selling GeneLink's genetic assessments and genetically influenced consumer products."

GeneLink Biosciences, Inc. (www.genelinkbio.com) is a 17-year old leading biosciences company specializing in consumer genomics. GeneLink's patented technologies include proprietary DNA assessments linked to personalized health, beauty and wellness applications and products. Its DNA assessments provide information that enables the customization of nutritional and skincare products designed and manufactured to fulfill each individual consumer's wellness needs.

Forward-looking Statements

This news release may contain "Forward-looking Statements" within the meaning of Section 21E of the United States Securities Exchange Act, as amended.  All statements in this news release, other than statements of historical fact, are forward-looking statements that involve various risks and uncertainties.  There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements.  This notice expressly qualifies all forward-looking statements in this news release.


'/>"/>
SOURCE GeneLink Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. GeneLink Marketing Efforts Poised to Show Results
2. GeneLink BioSciences, Inc. Ranked Number 33 Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
3. GeneLink Reports Second Quarter 2011 Results
4. GeneLink Biosciences Expands its Scientific Advisory Board to Support New Product Lines
5. GeneLink Reports Denial of Appeal
6. GeneLink Reports 2010 Results
7. GeneLink Announces New Licensing Partner
8. GeneLink Reports Third Quarter Results
9. GeneLink BioSciences, Inc. Ranked 62nd Fastest Growing Company in North America on Deloittes 2010 Technology Fast 500™
10. GeneLink Announces HelixLife Private Label Distribution Agreement
11. GeneLink Reports First Quarter Gains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2017)... ... May 16, 2017 , ... Clinical Supplies Management (“CSM”), a Great Point Partners ... to grow. CSM has doubled in size over the past six months with ... strategy. , Roger Gasper joins CSM as Chief Financial Officer. Roger has over ...
(Date:5/18/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... May 17, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the Chairman of the UDIs and Traceability for Medical Devices conference in Brussels, ...
(Date:5/18/2017)... ... May 18, 2017 , ... When James Sherley, was notified earlier this year that ... Brands for the Year 2017 by The Silicon Review , he was not surprised ... progress increasing Asymmetrex’s value, but this recognition by Silicon Valley was particularly meaningful. Our ...
(Date:5/16/2017)... , ... May 16, 2017 , ... ... and cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a ... cancer, this new test is designed to quickly and accurately identify tumor-related genetic ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
Breaking Biology News(10 mins):